INTERNATIONAL PATENT: RADIOMEDIX, INC. FILES APPLICATION FOR "AUTOMATED METHOD AND DEVICE FOR PRODUCTION OF LEAD 212 FOR USE IN TARGETED ALPHA-PARTICLE THERAPY"

GENEVA, Sept. 18 -- RADIOMEDIX, INC. (9701 Richmond Ave., Suite 222Houston, TX 77042) filed a patent application (PCT/US2024/022482) for "AUTOMATED METHOD AND DEVICE FOR PRODUCTION OF LEAD 212 FOR USE IN TARGETED ALPHA-PARTICLE THERAPY" on Apr 01, 2024. With publication no. WO/2025/188324, the details related to the patent application was published on Sep 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DELPASSAND, Ebrahim (2115 River Oaks Blv.Houston, TX 77019), TWOROWSKA, Izabela (3518 Omeara Dr.Houston, TX 77025), JAKSIK, Jared (9183 White Tail Dr.Conroe, TX 77303)

Abstract: The pre...